van Staa TP - Search Results

1

Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomes.

Gallagher AM, van Staa TP, Murray-Thomas T, Schoof N, Clemens A, Ackermann D, Bartels DB. Gallagher AM, et al. Among authors: van staa tp. BMJ Open. 2014 Jan 27;4(1):e003839. doi: 10.1136/bmjopen-2013-003839. BMJ Open. 2014. PMID: 24468720 Free PMC article.

2

Fracture outcomes related to persistence and compliance with oral bisphosphonates.

Gallagher AM, Rietbrock S, Olson M, van Staa TP. Gallagher AM, et al. Among authors: van staa tp. J Bone Miner Res. 2008 Oct;23(10):1569-75. doi: 10.1359/jbmr.080510. J Bone Miner Res. 2008. PMID: 18505366 Free article.

3

Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?

Gallagher AM, Rietbrock S, Plumb J, van Staa TP. Gallagher AM, et al. Among authors: van staa tp. J Thromb Haemost. 2008 Sep;6(9):1500-6. doi: 10.1111/j.1538-7836.2008.03059.x. Epub 2008 Jun 28. J Thromb Haemost. 2008. PMID: 18573187 Free article.

4

How effective are dose-adjusted warfarin and aspirin for the prevention of stroke in patients with chronic atrial fibrillation? An analysis of the UK General Practice Research Database.

Rietbrock S, Plumb JM, Gallagher AM, van Staa TP. Rietbrock S, et al. Among authors: van staa tp. Thromb Haemost. 2009 Mar;101(3):527-34. Thromb Haemost. 2009. PMID: 19277415

5

Utilization characteristics and treatment persistence in patients prescribed low-dose buprenorphine patches in primary care in the United Kingdom: a retrospective cohort study.

Gallagher AM, Leighton-Scott J, van Staa TP. Gallagher AM, et al. Among authors: van staa tp. Clin Ther. 2009 Aug;31(8):1707-15. doi: 10.1016/j.clinthera.2009.08.022. Clin Ther. 2009. PMID: 19808129

6

A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice.

Van Staa TP, Setakis E, Di Tanna GL, Lane DA, Lip GY. Van Staa TP, et al. J Thromb Haemost. 2011 Jan;9(1):39-48. doi: 10.1111/j.1538-7836.2010.04085.x. J Thromb Haemost. 2011. PMID: 21029359 Free article.

7

Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data.

van Staa TP, Patel D, Gallagher AM, de Bruin ML. van Staa TP, et al. Diabetologia. 2012 Mar;55(3):654-65. doi: 10.1007/s00125-011-2390-3. Epub 2011 Nov 30. Diabetologia. 2012. PMID: 22127412

8

Risk of death and cardiovascular outcomes with thiazolidinediones: a study with the general practice research database and secondary care data.

Gallagher AM, Smeeth L, Seabroke S, Leufkens HG, van Staa TP. Gallagher AM, et al. Among authors: van staa tp. PLoS One. 2011;6(12):e28157. doi: 10.1371/journal.pone.0028157. Epub 2011 Dec 2. PLoS One. 2011. PMID: 22164237 Free PMC article.

9

Quality of INR control and outcomes following venous thromboembolism.

Gallagher AM, de Vries F, Plumb JM, Haß B, Clemens A, van Staa TP. Gallagher AM, et al. Among authors: van staa tp. Clin Appl Thromb Hemost. 2012 Jul;18(4):370-8. doi: 10.1177/1076029611426139. Epub 2012 Jan 23. Clin Appl Thromb Hemost. 2012. PMID: 22275390 Free article.

10

Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?

Bazelier MT, Gallagher AM, van Staa TP, Cooper C, Leufkens HG, Vestergaard P, de Vries F. Bazelier MT, et al. Among authors: van staa tp. Pharmacoepidemiol Drug Saf. 2012 May;21(5):507-14. doi: 10.1002/pds.3234. Epub 2012 Mar 6. Pharmacoepidemiol Drug Saf. 2012. PMID: 22392882

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

289 results

Search Page